Introducing Psychadelta: A Community-Driven Initiative to Advance Psychedelic Clinical Research
Clinically Media, a leader in patient recruitment and clinical trial engagement, is proud to announce the launch of Psychadelta, a new program under its Clinically Trials brand designed to bring together patients, professionals, and passionate supporters of psychedelic research. This program has been developed in partnership with Photosynthesis Creative Studio.
As interest in psychedelic medicine grows, so does the need for accurate, accessible information and meaningful community connection. Psychadelta is Clinically Media’s answer to that need—a place where clarity, connection, and change intersect.
“We launched Psychadelta to give people a trusted, welcoming space to learn about psychedelic clinical trials, engage with experts, and connect with others who are just as curious and passionate. This is more than a database or a newsletter—it’s a community.”
Psychadelta’s Foundational Pillars
Connection – Opportunities to connect with like-minded individuals both virtually and in person
Clarity – Straightforward updates that help people understand what research findings actually mean
Change – A chance to actively shape the future of psychedelic medicine by participating in clinical trials
Why now?
Psychedelic clinical trials are increasing in number and scope, with new therapies being evaluated for conditions like PTSD, depression, anxiety, and addiction. Our patients are looking to us for trustworthy updates or understand how to get involved. Psychadelta aims to fill that need—with integrity, empathy, and scientific rigor.
Getting Involved
FOR RESEARCH SITES
Are you a Schedule I psychedelic research site?
Join our growing registry of psychedelic research locations. By adding your site, you'll make it easier for qualified patients to find your studies—and easier for sponsors and partners to connect with you. Include a link to your currently enrolling trials, and let Psychadelta help amplify your reach.
→ Submit your site to the registry today (complimentary!).
FOR INDUSTRY
Running a psychedelic clinical trial? Our patients want to participate in your studies.
Clinically Trials and the Psychadelta community are here to help you meet your enrollment goals—ethically, efficiently, and with the right patients. Sign up for our Advisory List to stay up to date on evolving patient needs and preferences, and partner with us to promote your trial through a network of engaged, educated individuals who care about the future of psychedelic medicine.
→ Get in touch to get your study enrolled.
FOR PATIENTS
Curious about psychedelic research—and how to get involved?
Join the Psychadelta Advisory List to shape how psychedelic studies are shared and supported. Then, sign up for alerts on ClinicallyTrials.com to be notified when studies you care about—psychedelic and beyond—open in your area.
This is your chance to stay informed, get involved, and be part of something bigger.
→ Sign up now.
FOR ALL
Psychadelta is launching with a small group of volunteer advisors whose feedback will shape the future of the platform—helping Clinically Trials refine how it shares stories, translates complex medical information, and supports the people behind the progress.
Contact psychadelta@gmail.com with questions or comments.
Follow along on Instagram @psychadelta.
